Molecular Partners AG (MOLN) Earnings Date & Reports
Molecular Partners AG is a clinical stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MOLN is expected to report earnings to fall 29.95% to -47 cents per share on October 30
Q3'25
Est.
$-0.48
Q2'25
Missed
by $0.19
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.33
Q3'24
Beat
by $0.07
The last earnings report on August 25 showed earnings per share of -68 cents, missing the estimate of -49 cents. With 1.90K shares outstanding, the current market capitalization sits at 134.88M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MOLN showed earnings on August 25, 2025. You can read more about the earnings report here.